{
  "nct_id": "NCT61118479",
  "indication": "Parkinson's Disease",
  "phase": "Phase 2/3",
  "sample_size": 892,
  "duration_weeks": 74,
  "dropout_rate": 0.3,
  "blinding": "double-blind",
  "control_arm": "placebo",
  "primary_endpoints": [
    "UPDRS score improvement"
  ],
  "secondary_endpoints": [
    "ON time without dyskinesia",
    "OFF time reduction"
  ],
  "outcome_summary": "Failed to reach statistical significance on primary endpoint",
  "success": 0,
  "failure_reason": "High dropout rate affected statistical analysis",
  "start_date": "2019-04-07",
  "completion_date": "2020-09-06"
}